U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C5H6N2
Molecular Weight 94.1145
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 2-AMINOPYRIDINE

SMILES

NC1=NC=CC=C1

InChI

InChIKey=ICSNLGPSRYBMBD-UHFFFAOYSA-N
InChI=1S/C5H6N2/c6-5-3-1-2-4-7-5/h1-4H,(H2,6,7)

HIDE SMILES / InChI

Molecular Formula C5H6N2
Molecular Weight 94.1145
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Evaluation of pyridoindoles, pyridylindoles and pyridylpyridoindoles as matrices for ultraviolet matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
2001
Structures of the N-linked sugar chains in PAS-7 glycoprotein sharing the same protein core with PAS-6 glycoprotein from the bovine milk fat globule membrane.
2001 Apr
Triclinic polymorph of sulfasalazine.
2001 Apr
A synthetic analogue of the active site of Fe-containing nitrile hydratase with carboxamido N and thiolato S as donors: synthesis, structure, and reactivities.
2001 Apr 11
Structural characterization of fucose-containing oligosaccharides by high-performance liquid chromatography and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
2001 Feb
Validation of a CE assay for the analysis of isomeric aminopyridines and diaminopyridines.
2001 Feb
Preparation, characterization and crystal structures of manganese(II), iron(III) and copper(II) complexes of the bi.
2001 Jan
DNA-interactive anticancer aza-anthrapyrazoles: biophysical and biochemical studies relevant to the mechanism of action.
2001 Jan
Theoretical analysis of the molecular determinants responsible for the K(+) channel blocking by aminopyridines.
2001 Jun 15
Inhibition of class C beta-lactamases: structure of a reaction intermediate with a cephem sulfone.
2001 May 29
Glycoproteins secreted from suspension-cultured tobacco BY2 cells have distinct glycan structures from intracellular glycoproteins.
2001 Nov
Spectral characteristics of 2-(4'-N,N-dimethylaminophenyl)pyrido[3,4-d]imidazole in AOT/n-heptane/water reverse micelles.
2001 Nov
High-performance liquid chromatography analysis of ganglioside carbohydrates at the picomole level after ceramide glycanase digestion and fluorescent labeling with 2-aminobenzamide.
2001 Nov 15
In vivo conversion of a glycan to human compatible type by transformed tobacco cells.
2001 Nov 30
Apoptosis induced by picolinic acid-related compounds in HL-60 cells.
2001 Oct
Structural analysis of the sugar chains of human urinary thrombomodulin.
2001 Oct
Neuronal nicotinic receptor agonists: a multi-approach development of the pharmacophore.
2001 Sep
Synthesis and anti-HIV activity of some isatin derivatives.
2001 Sep-Oct
Properties of some alkyl substituted phthalocyanines and related macrocycles.
2002
Analysis of fluorogenic Smith degradation products of 7-(1,3-disulfonaphtyl)amino-disaccharides for linkage position analysis of carbohydrates.
2002 Dec
[N.1.1]-(2,6)-Pyridinophanes: a new ligand type imposing unusual metal coordination geometries.
2002 Dec 16
Syntheses and magnetic properties of hexanuclear [Cp2Mn3(L1)4]2 and octanuclear [Mn8(L2)12(mu 4-O)2] (L1 = 2-HNC5H5N, L2 = 2-NH-3-Br-5-MeC5H3N, Cp = C5H5).
2002 Dec 21
An NMR investigation of the conformational equilibria of 2-(2'-pyridyl)ethylphosphonic acid in several solvents.
2002 Feb-Mar
Discovery of aminopyridine-based inhibitors of bacterial enoyl-ACP reductase (FabI).
2002 Jul 18
Oxidative damage due to copper ion and hydrogen peroxide induces GlcNAc-specific cleavage of an Asn-linked oligosaccharide.
2002 Mar
Synthesis of some novel quinoline-3-carboxylic acids and pyrimidoquinoline derivatives as potential antimicrobial agents.
2002 Nov
Amination of pyridylketenes: experimental and computational studies of strong amide enol stabilization by the 2-pyridyl group.
2002 Nov 20
Antitumor agents. 2. Synthesis, structure-activity relationships, and biological evaluation of substituted 5H-pyridophenoxazin-5-ones with potent antiproliferative activity.
2002 Nov 21
Antitumor agents. 1. Synthesis, biological evaluation, and molecular modeling of 5H-pyrido[3,2-a]phenoxazin-5-one, a compound with potent antiproliferative activity.
2002 Nov 21
Homoazanicotine: a structure-affinity study for nicotinic acetylcholine (nACh) receptor binding.
2002 Oct 10
The unusual role of CO transfer in molybdenum-catalyzed asymmetric alkylations.
2002 Oct 30
Potent and selective inhibitors of PDGF receptor phosphorylation. 2. Synthesis, structure activity relationship, improvement of aqueous solubility, and biological effects of 4-[4-(N-substituted (thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline derivatives.
2002 Sep 26
Regioselective substitution of 6,7-dichloroquinoline-5,8-dione: synthesis and X-ray crystal structure of 4a,10,11-triazabenzo[3,2-a]fluorene-5,6-diones.
2003 Apr 17
Distance dependence of electron transfer across peptides with different secondary structures: the role of Peptide energetics and electronic coupling.
2003 Apr 2
Reduced inotropic heart response in selenium-deficient mice relates with inducible nitric oxide synthase.
2003 Feb
Magnetic interaction of pyridyl-substituted thioaminyl stable free radicals.
2003 Feb 21
Selective complex formation of some chromogenic calix[4]arene derivatives detected by Fourier transform infrared spectroscopy 1. Solution experiments.
2003 Jan 1
An HIV reverse transcriptase-selective nucleoside chain terminator.
2003 Jan 22
NMR evaluation of the configurational stability of Cu(I) complexes.
2003 Jan 27
Structural chemistry and In vitro antitubercular activity of acetylpyridine benzoyl hydrazone and its copper complex against Mycobacterium smegmatis.
2003 Jan 6
Localization of defined carbohydrate epitopes in bovine polysialylated NCAM.
2003 Jan-Feb
N-glycan structures of human transferrin produced by Lymantria dispar (gypsy moth) cells using the LdMNPV expression system.
2003 Jul
Speciation study of the anti-inflammatory drug tenoxicam (Htenox) with Cu(II): X-ray crystal structure of [Cu(tenox)(2)(py)(2)].EtOH.
2003 Jun 1
Investigations into the interactions between DNA and conformationally constrained pyridylamineplatinum(II) analogues of AMD473.
2003 Jun 2
Bis(2-aminopyridinium) maleate.
2003 Mar
Plant cultured cells expressing human beta1,4-galactosyltransferase secrete glycoproteins with galactose-extended N-linked glycans.
2003 Mar
Thermodynamic, kinetic and structural studies on the mixed ligand complexes of palladium(II) with tridentate and monodentate ligands.
2003 Mar 1
Patents
Substance Class Chemical
Created
by admin
on Fri Dec 15 17:20:48 GMT 2023
Edited
by admin
on Fri Dec 15 17:20:48 GMT 2023
Record UNII
WSX981HEWU
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
2-AMINOPYRIDINE
HSDB  
Systematic Name English
MEPYRAMINE MALEATE IMPURITY C [EP IMPURITY]
Common Name English
NSC-431
Code English
.ALPHA.-AMINOPYRIDINE
MI  
Common Name English
TENOXICAM IMPURITY A [EP IMPURITY]
Common Name English
.ALPHA.-AMINOPYRIDINE [MI]
Common Name English
2-PYRIDINAMINE
Systematic Name English
PYRIDIN-2-AMINE
Systematic Name English
PIROXICAM RELATED COMPOUND A [USP-RS]
Common Name English
2-AMINOPYRIDINE [HSDB]
Common Name English
AMINOPYRIDINE, 2-
Systematic Name English
PIROXICAM IMPURITY A [EP IMPURITY]
Common Name English
Code System Code Type Description
SMS_ID
100000142926
Created by admin on Fri Dec 15 17:20:48 GMT 2023 , Edited by admin on Fri Dec 15 17:20:48 GMT 2023
PRIMARY
HSDB
2068
Created by admin on Fri Dec 15 17:20:48 GMT 2023 , Edited by admin on Fri Dec 15 17:20:48 GMT 2023
PRIMARY
MERCK INDEX
m1739
Created by admin on Fri Dec 15 17:20:48 GMT 2023 , Edited by admin on Fri Dec 15 17:20:48 GMT 2023
PRIMARY Merck Index
EPA CompTox
DTXSID0024505
Created by admin on Fri Dec 15 17:20:48 GMT 2023 , Edited by admin on Fri Dec 15 17:20:48 GMT 2023
PRIMARY
CAS
504-29-0
Created by admin on Fri Dec 15 17:20:48 GMT 2023 , Edited by admin on Fri Dec 15 17:20:48 GMT 2023
PRIMARY
PUBCHEM
10439
Created by admin on Fri Dec 15 17:20:48 GMT 2023 , Edited by admin on Fri Dec 15 17:20:48 GMT 2023
PRIMARY
MESH
C032439
Created by admin on Fri Dec 15 17:20:48 GMT 2023 , Edited by admin on Fri Dec 15 17:20:48 GMT 2023
PRIMARY
NSC
431
Created by admin on Fri Dec 15 17:20:48 GMT 2023 , Edited by admin on Fri Dec 15 17:20:48 GMT 2023
PRIMARY
WIKIPEDIA
2-AMINOPYRIDINE
Created by admin on Fri Dec 15 17:20:48 GMT 2023 , Edited by admin on Fri Dec 15 17:20:48 GMT 2023
PRIMARY
ECHA (EC/EINECS)
207-988-4
Created by admin on Fri Dec 15 17:20:48 GMT 2023 , Edited by admin on Fri Dec 15 17:20:48 GMT 2023
PRIMARY
RS_ITEM_NUM
1544519
Created by admin on Fri Dec 15 17:20:48 GMT 2023 , Edited by admin on Fri Dec 15 17:20:48 GMT 2023
PRIMARY
FDA UNII
WSX981HEWU
Created by admin on Fri Dec 15 17:20:48 GMT 2023 , Edited by admin on Fri Dec 15 17:20:48 GMT 2023
PRIMARY
EVMPD
SUB117598
Created by admin on Fri Dec 15 17:20:48 GMT 2023 , Edited by admin on Fri Dec 15 17:20:48 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
PARENT -> IMPURITY
correction factors: for the calculation of content, multiply the peak areas of the following impurities by the corresponding correction factor: impurity A = 0.2
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
PARENT -> IMPURITY
For the calculation of contents, multiply the peak areas by 0.6
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Related Record Type Details
ACTIVE MOIETY